comparemela.com

Latest Breaking News On - Nasdaq listing rule - Page 12 : comparemela.com

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement.

Encephalopathies-dees
Nasdaq
Longboard-pharmaceuticals-inc
Exchange-commission
Longboard-pharmaceuticals
Compensation-committee
Nasdaq-listing-rule
Common-stock
Epileptic-encephalopathies
Private-securities-litigation-reform-act

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., June 3, 2024 /PRNewswire/ Spyre Therapeutics, Inc. , a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations,.

Linkedin
Prnewswire-spyre-therapeutics-inc
Nasdaq
Compensation-committee-of-the-board-directors
Company-or-spyre
Spyre-therapeutics-inc
Inflammatory-bowel-disease
Compensation-committee
Spyre-therapeutics
Inducement-plan
Nasdaq-listing-rule

Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Boston
Zapata-ai-compensation-committee
Zapata-computing-holdings-inc
Company-nasdaq
Computing-holdings
Industrial-generative
Compensation-committee
Derron-blakely
Incentive-plan

CNEY Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

LISHUI, China, June 3, 2024 /PRNewswire/ CN Energy Group. Inc. today announced that it received a written notice from The Nasdaq Stock Market LLC on May 28, 2024. The Notice notifies that the.

Lishui
Zhejiang
China
Source-cn-energy-group
Company-class
Prnewswire-cn-energy-group
Nasdaq
Cn-energy-group
Nasdaq-stock-market
Nasdaq-listing-rules
Nasdaq-capital

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 4 newly-hired employees options to purchase an aggregate of 76,000 shares of Akebia's common stock on May 31,.

Cambridge
Cambridgeshire
United-kingdom
Massachusetts
United-states
Mercedes-carrasco
Nasdaq
Akebia-therapeutics-inc
Akebia-therapeutics
Nasdaq-listing-rule

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.